|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 223.67 USD | -1.66% |
|
+0.30% | +25.87% |
| 12-15 | RedHill Biopharma Ltd.'s Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells | CI |
| 12-15 | AbbVie's Upside Potential Limited in Pipeline-Light 2026, BofA Securities Says | MT |
Highlights
Search
12-15 | CI | |
12-08 | CI | |
12-02 | CI | |
12-01 | CI | |
12-01 | CI | |
11-28 | CI | |
11-26 | MT | |
11-20 | RE | |
11-19 | RE | |
11-18 | CI | |
11-18 | MT | |
11-18 | ||
11-17 | RE | |
11-17 | CI | |
11-17 | CI | |
11-14 | CI | |
11-12 | MT | |
11-12 | MT | |
11-12 | MT | |
11-07 | CI | |
11-07 | RE | |
11-05 | RE | |
11-04 | CI | |
10-31 | MT | |
10-31 | RE |
No results for this search
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Highlights
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















